Latest Regulatory News

Island Pharmaceuticals has confirmed the material significance of recent FDA feedback on its Galidesivir development pathway and addressed ASX queries on disclosure timing and capital raising activities.

Electro Optic Systems (EOS) has firmly rejected allegations from a recent Grizzly Research report, highlighting its strengthened financial position, significant contract wins, and strategic acquisition to bolster its defence technology portfolio.

Orbminco Limited has issued 62.5 million shares to raise $1 million as part of a staged capital raising, with shareholder approval for the next tranche expected in March.

Brightstar Resources has launched a $5 million Share Purchase Plan offering eligible shareholders discounted shares to fund key mining projects. The offer opens on 10 February and closes on 27 February 2026.

The Takeovers Panel has declared unacceptable circumstances in Identitii Limited's recent rights issue, ordering supplementary disclosure and a reopening of the offer to protect shareholder interests and market integrity.

Godolphin Resources has identified a significant new induced polarisation anomaly 1,000 metres from its Lewis Ponds deposit, alongside high-grade gold, zinc, and copper surface samples, setting the stage for a targeted drilling campaign in March 2026.

Revolution Private Credit Income Trust has launched a A$60 million institutional placement at A$2.00 per unit, aiming to bolster its investment in senior secured loans across Australia and New Zealand. The trust targets a net yield to maturity of 7.83%, emphasizing disciplined risk management and transparency.

NexGen Energy is advancing through the final Canadian Nuclear Safety Commission hearing for its Rook I uranium project, buoyed by strong Indigenous community support and over a decade of environmental and social groundwork.

European Metals Holdings has achieved a critical rezoning approval for its flagship Cinovec Lithium Project, unlocking defined mining and processing zones. Backed by substantial Czech and EU government grants, the project is poised to become Europe’s largest hard rock lithium producer.

G8 Education has announced a significant $350 million goodwill impairment for FY25, reflecting ongoing sector pressures. Despite this, the company maintains its EBIT guidance but suspends dividends and pauses its share buyback program.

EVE Health Group has officially launched Libbo™, an oral dissolving film for erectile dysfunction, alongside a new digital platform aimed at improving men’s health access and education across Australia.

American Uranium Limited has upgraded its U.S. trading status to the OTCQB Venture Market, enhancing liquidity and accessibility for North American investors. This move supports the company’s strategy to expand its U.S. shareholder base and increase visibility for its flagship uranium project in Wyoming.